| Year |
Citation |
Score |
| 2015 |
Sun YW, Chen KY, Kwon CH, Chen KM. CK0403, a 9‑aminoacridine, is a potent anti‑cancer agent in human breast cancer cells. Molecular Medicine Reports. PMID 26648164 DOI: 10.3892/Mmr.2015.4604 |
0.334 |
|
| 2014 |
Wang J, Wang YJ, Chen ZS, Kwon CH. Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3'-azido-3'-deoxythymidine as anticancer prodrugs. Bioorganic & Medicinal Chemistry. 22: 5747-56. PMID 25440502 DOI: 10.1016/J.Bmc.2014.09.046 |
0.436 |
|
| 2010 |
Sun YW, Niu TK, Yang JM, Kwon CH, Chen KY, Chen KM. Potentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cells. Experimental and Therapeutic Medicine. 1: 513-518. PMID 22993569 DOI: 10.3892/Etm_00000081 |
0.339 |
|
| 2010 |
Sun Y, Olson TL, Kwon C, Chen K. Abstract 4576: Quantitative proteomic analysis of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) modulated protein expression in breast cancer SKBR-3 cells Cancer Research. 70: 4576-4576. DOI: 10.1158/1538-7445.Am10-4576 |
0.32 |
|
| 2010 |
Kung CH, Kwon CH. Carbamate derivatives of felbamate as potential anticonvulsant agents Medicinal Chemistry Research. 19: 498-513. DOI: 10.1007/S00044-009-9208-6 |
0.525 |
|
| 2008 |
Park SK, Kang H, Kwon CH. Caspase-dependent cell death mediates potent cytotoxicity of sulfide derivatives of 9-anilinoacridine. Anti-Cancer Drugs. 19: 381-9. PMID 18454048 DOI: 10.1097/Cad.0B013E3282F9Adb2 |
0.342 |
|
| 2006 |
Sun YW, Chen KM, Kwon CH. Sulfonyl-containing nucleoside phosphotriesters and phosphoramidates as novel anticancer prodrugs of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP). Molecular Pharmaceutics. 3: 161-73. PMID 16579645 DOI: 10.1021/Mp0500622 |
0.431 |
|
| 2005 |
Chen KM, Sun YW, Tang YW, Sun ZY, Kwon CH. Synthesis and antitumor activity of sulfur-containing 9-anilinoacridines. Molecular Pharmaceutics. 2: 118-28. PMID 15804186 DOI: 10.1021/Mp049913G |
0.451 |
|
| 2004 |
Jain M, Fan J, Baturay NZ, Kwon CH. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines. Journal of Medicinal Chemistry. 47: 3843-52. PMID 15239662 DOI: 10.1021/Jm0304764 |
0.439 |
|
| 2003 |
Jain M, Kwon CH. 1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation. Journal of Medicinal Chemistry. 46: 5428-36. PMID 14640551 DOI: 10.1021/Jm020581Y |
0.4 |
|
| 2000 |
Sun Z, Botros E, Su A, Kim Y, Wang E, Baturay NZ, Kwon C. Sulfoxide-containing aromatic nitrogen mustards as hypoxia-directed bioreductive cytotoxins. Journal of Medicinal Chemistry. 43: 4160-4168. PMID 11063612 DOI: 10.1021/Jm9904957 |
0.36 |
|
| 1999 |
Kung C, Wurpel JND, Kwon C. Synthesis and structure activity study of N-1 substituted (S)-(+)-5-n-propyl-2-iminohydantoins as potential anticonvulsant agents Drug Development Research. 47: 17-26. DOI: 10.1002/(Sici)1098-2299(199905)47:1<17::Aid-Ddr3>3.0.Co;2-# |
0.519 |
|
| 1995 |
Moon KY, Shirota FN, Baturay N, Kwon CH. Chemically stable N-methyl-4-(alkylthio)cyclophosphamide derivatives as prodrugs of 4-hydroxycyclophosphamide. Journal of Medicinal Chemistry. 38: 848-51. PMID 7877150 DOI: 10.1021/JM00005A012 |
0.34 |
|
| 1994 |
Sun ZY, Kwon CH, Wurpel ND. Structure-activity study of 5-substituted 1-carbobenzoxy-2-iminohydantoins as potential anticonvulsant agents. Journal of Medicinal Chemistry. 37: 2841-5. PMID 8071932 DOI: 10.1021/JM00044A003 |
0.393 |
|
| 1991 |
Kwon CH, Iqbal MT, Wurpel JN. Synthesis and anticonvulsant activity of 2-iminohydantoins. Journal of Medicinal Chemistry. 34: 1845-9. PMID 2061925 DOI: 10.1021/JM00110A013 |
0.347 |
|
| Show low-probability matches. |